At the Shanghai Center of GoBroad Medical Institute of Hematology, we are committed to giving patients with multiple myeloma the best care possible. Under the direction of Professor Wang Chun, a skilled hematologist with more than 30 years of clinical background, our facility provides a thorough method for identifying and treating this intricate blood condition. Our committed team of experts works to provide individualized care based on the most recent advancements in multiple myeloma diagnosis and treatment.

What Is Multiple Myeloma

Multiple myeloma is a cancer that affects plasma cells in the bone marrow. These cells are responsible for producing antibodies, and when they become cancerous, they can interfere with the production of healthy blood cells, leading to complications such as anemia, kidney damage, and weakened bones. Early diagnosis is important to manage symptoms and plan an appropriate course of treatment.

Accurate Diagnosis for Effective Treatment

At GoBroad, our multiple myeloma diagnosis and treatment carried out using advanced diagnostic methods, including bone marrow biopsy, flow cytometry, and genetic testing. These diagnostic tools help us understand the disease’s progression and determine the best treatment approach for each patient.

Role of Hematopoietic Stem Cell Transplantation (HSCT) in Multiple Myeloma Treatment

For patients with multiple myeloma, hematopoietic stem cell transplantation (HSCT) can be an important treatment option, particularly when the disease has not responded well to initial treatments. At GoBroad, we have experience in performing HSCT for multiple myeloma diagnosis and treatment, especially in cases where other therapies have not been effective.

The procedure involves using high-dose chemotherapy to destroy cancerous cells in the bone marrow, followed by the infusion of healthy stem cells to restore normal bone marrow function. This approach can help improve survival rates and quality of life for eligible patients, but it is typically recommended based on individual patient factors.

Personalized Care for Multiple Myeloma Patients

We believe that each patient’s journey is unique, which is why we take a personalized approach to multiple myeloma treatment. Our multidisciplinary team includes hematologists, oncologists, and other specialists, all of whom collaborate to create a treatment plan that suits each patient’s medical needs. Additionally, our team provides ongoing support to help patients manage any side effects from treatments and to ensure they receive the care they need at every stage of their treatment.

Conclusion

If you or a loved one is diagnosed with multiple myeloma, GoBroad Medical Institute of Hematology (Shanghai Center) offers comprehensive diagnosis and treatment options designed to manage the disease effectively. Led by Professor Wang Chun and supported by a skilled team of medical professionals, we provide personalized care and advanced treatment strategies to improve the outcomes for patients with multiple myeloma. Contact us today to learn more about our services and how we can assist you with your diagnosis and treatment needs.